Who Buys Doxycycline from India — 1051 Importers Behind a $118.6M Market
India's doxycycline import market is served by 1051 active buyers who collectively imported $118.6M across 5,999 shipments. EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with a 30.8% market share, followed by AVET PHARMACEUTICALS INC and J KNIPPER COMPANY. The top 5 buyers together control 57.2% of total import value, reflecting a moderately competitive buyer landscape.
Top Doxycycline Importers — Ranked by Import Value
EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) is the leading doxycycline importer from India, holding a 30.8% share of the $118.6M market across 5,999 shipments from 1051 buyers. The top 5 buyers — EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), AVET PHARMACEUTICALS INC (UNITED STATES), J KNIPPER COMPANY (UNITED STATES), J. KNIPPER & COMPANY (UNITED STATES), AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES) — collectively control 57.2% of total import value.
Top Doxycycline Buyers & Importers
Ranked by import value · 1051 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $36.6M | 5 | 30.8% |
| 2 | AVET PHARMACEUTICALS INCUNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $20.6M | 5 | 17.4% |
| 3 | J KNIPPER COMPANYUNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP USDOXY -200 TABLETS B/8 (DOXYCYCLINE MONOH | $4.0M | 5 | 3.4% |
| 4 | J. KNIPPER & COMPANYUNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $3.4M | 5 | 2.8% |
| 5 | AMNEAL PHARMACEUTICALS, LLC (KY)UNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $3.3M | 5 | 2.8% |
| 6 | MYLAN INSTITUTIONAL INC 2898UNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $3.2M | 5 | 2.7% |
| 7 | MYLAN INSTITUTIONAL INCUNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $3.0M | 5 | 2.5% |
| 8 | J. KNIPPER & COMPANY,UNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $2.9M | 5 | 2.4% |
| 9 | NORTHSTAR DISTRIBUTION CENTER 8912UNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $2.7M | 5 | 2.2% |
| 10 | CARDINAL THIRD PARTY LOGISTICSUNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $2.4M | 5 | 2.0% |
| 11 | ETHIOPIAN PHARMACEUTICALS SUPPLY AGETHIOPIA DOXYZIM 100 (DOXYCYCLINE CAPSULES BP 100DOXYZIM 100DOXYZIM 100 DOXYCYCLINE CAPSULES BP 100MG | $1.5M | 5 | 1.3% |
| 12 | AMNEAL PHARMACEUTICALS LLC KYUNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $1.5M | 5 | 1.3% |
| 13 | APOTEX PTY LTD.,AUSTRALIA APX-DOXYCYCLINE DOXYCYCLINE TABLETS [100DOXSIG DOXYCYCLINE TABLETS [100MG] 185,3APX-DOXYCYCLINE DOXYCYCLINE TABLETS [50M | $1.0M | 5 | 0.9% |
| 14 | ZYDUS PHARMACEUTICALS USA INCUNITED STATES DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $914.8K | 5 | 0.8% |
| 15 | DRUGSRUS LIMITEDUNITED KINGDOM | $851.9K | 5 | 0.7% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Doxycycline — and from which countries?
Flow of Doxycycline exports from India: each country's share and the named importers behind the numbers
Doxycycline — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $93.2M through 436 shipments. This represents a market share of 78.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCE SERVICES - $36.6M (39.2% of country's total business)
• AVET PHARMACEUTICALS INC - $20.6M (22.1% of country's total business)
• J KNIPPER COMPANY - $4.0M (4.3% of country's total business)
• J. KNIPPER & COMPANY - $3.4M (3.6% of country's total business)
• AMNEAL PHARMACEUTICALS, LLC (KY) - $3.3M (3.6% of country's total business)
• Rest of United States's importers - $25.4M (27.2% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $213.8K, indicating premium pricing strategy compared to the market average of $19.8K.
United States is a key market for Doxycycline imports, representing 78.6% of total trade value.
2Australia
Australia emerges as the second largest importing country, achieving a total trade value of $4.7M through 25 shipments. This represents a market share of 4.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• APOTEX PTY LTD., - $1.0M (22.2% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $188.2K, indicating premium pricing strategy compared to the market average of $19.8K.
Australia is a key market for Doxycycline imports, representing 4.0% of total trade value.
3Ethiopia
Ethiopia emerges as the third largest importing country, achieving a total trade value of $2.4M through 13 shipments. This represents a market share of 2.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Ethiopia has a diverse importer base, with their top importers including:
• ETHIOPIAN PHARMACEUTICALS SUPPLY AG - $1.5M (63.3% of country's total business)
Key Insight: Ethiopia demonstrates strong market positioning with an average shipment value of $185.8K, indicating premium pricing strategy compared to the market average of $19.8K.
Ethiopia is a key market for Doxycycline imports, representing 2.0% of total trade value.
4United Kingdom
United Kingdom emerges as the fourth largest importing country, achieving a total trade value of $2.3M through 41 shipments. This represents a market share of 1.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• DRUGSRUS LIMITED - $851.9K (37.5% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $55.4K, indicating premium pricing strategy compared to the market average of $19.8K.
United Kingdom is a key market for Doxycycline imports, representing 1.9% of total trade value.
5Belgium
Belgium emerges as the fifth largest importing country, achieving a total trade value of $1.8M through 0 shipments. This represents a market share of 1.5% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $1.8M, indicating premium pricing strategy compared to the market average of $19.8K.
Belgium is a key market for Doxycycline imports, representing 1.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Doxycycline buyer market intelligence
1Buyer Segment Analysis
The top 10 buyers of Doxycycline from India predominantly fall into the following categories:
1. Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES, AVET PHARMACEUTICALS INC, and J. KNIPPER & COMPANY are major distributors in the United States. They procure large volumes to supply pharmacies, hospitals, and healthcare providers. Their purchasing behavior is characterized by bulk orders and long-term contracts to ensure consistent supply chains.
2. Contract Manufacturers: Companies such as AMNEAL PHARMACEUTICALS, LLC and MYLAN INSTITUTIONAL INC engage in contract manufacturing. They source active pharmaceutical ingredients (APIs) like Doxycycline for formulation and packaging under various brand names. Their procurement patterns involve substantial quantities aligned with production schedules and market demand forecasts.
3. Third-Party Logistics Providers: CARDINAL THIRD PARTY LOGISTICS represents logistics firms specializing in the storage and distribution of pharmaceutical products. They purchase Doxycycline to manage inventory for multiple clients, ensuring timely delivery to end-users. Their buying behavior is influenced by client needs and market dynamics, leading to variable order sizes and frequencies.
Each segment's purchasing patterns reflect their roles within the pharmaceutical supply chain, with distributors focusing on volume and consistency, contract manufacturers on production requirements, and logistics providers on flexible inventory management.
Country-Specific Import Regulations
TransData Nexus Doxycycline buyer market intelligence
1Country-Specific Import Regulations
United States
1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must file an entry notice and bond with U.S. Customs and Border Protection. The FDA reviews the entry for compliance, which may include sampling and laboratory analysis. Affirmation of Compliance codes, such as Drug Registration Number (REG) and Drug Listing Number (DLS), are recommended to expedite the process.
3. Estimated Timeline for Registration: The review process varies; however, providing complete and accurate documentation can expedite clearance.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this code are generally duty-free, but importers should verify current rates with U.S. Customs.
Australia
1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).
2. Import Registration Process: Medicines must be listed or registered in the Australian Register of Therapeutic Goods (ARTG). Importers must ensure compliance with TGA standards, including Good Manufacturing Practice (GMP) certification.
3. Estimated Timeline for Registration: The registration process can take several months, depending on the complexity of the application and the product's risk classification.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are typically duty-free, but importers should confirm with the Australian Border Force.
Ethiopia
1. Drug Regulatory Authority: Ethiopian Food and Drug Authority (EFDA).
2. Import Registration Process: Importers must obtain pre-import approval from the EFDA, ensuring products meet national standards and are registered accordingly.
3. Estimated Timeline for Registration: The process can take several months, contingent on the completeness of the application and regulatory reviews.
4. Import Tariff/Duty for HS 30049099: Import duties vary; importers should consult the Ethiopian Revenue and Customs Authority for current rates.
United Kingdom
1. Drug Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
2. Import Registration Process: Medicines must be authorized by the MHRA. Importers need a Wholesale Dealer's License, and products must comply with UK standards. The UK recognizes certain countries for importation under specific conditions. (gov.uk)
3. Estimated Timeline for Registration: Timelines vary; straightforward applications may take several months.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally exempt from import duties, but confirmation with HM Revenue & Customs is advisable.
Belgium
1. Drug Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
2. Import Registration Process: Medicines must be authorized by the FAMHP. Importers require a Wholesale Distribution Authorization, and products must comply with EU regulations.
3. Estimated Timeline for Registration: The process can take several months, depending on the product and completeness of the application.
4. Import Tariff/Duty for HS 30049099: As part of the EU, Belgium typically applies a zero-duty rate on pharmaceutical products, but importers should verify with Belgian Customs.
Demand Drivers & Market Opportunity
TransData Nexus Doxycycline buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Doxycycline in importing countries is driven by several factors:
1. Disease Prevalence: Doxycycline is widely used to treat bacterial infections such as respiratory tract infections, acne, and sexually transmitted infections. Its efficacy against a broad spectrum of bacteria makes it a staple in treatment protocols.
2. Government Healthcare Programs: Many countries have national health programs that include Doxycycline in their formularies, ensuring its availability to the population. For instance, the inclusion of Doxycycline in the WHO Model List of Essential Medicines underscores its importance in public health. (who.int)
3. Universal Health Coverage Expansion: As nations strive to achieve universal health coverage, the demand for essential medicines like Doxycycline increases to meet the healthcare needs of the population.
4. WHO Essential Medicines List Procurement: The inclusion of Doxycycline in the WHO Essential Medicines List facilitates its procurement by international health organizations and governments, ensuring its availability in resource-limited settings.
5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender systems, which can lead to bulk purchasing of Doxycycline, influencing market dynamics and pricing.
With 1,051 buyers across 149 countries, the global reach of Doxycycline underscores its critical role in healthcare systems worldwide. The combination of disease prevalence, supportive healthcare policies, and strategic procurement practices continues to drive its demand and presents ongoing market opportunities.
Common Questions — Doxycycline Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest doxycycline buyer importing from India?
Based on import volume and value, EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with $36.6M in imports and a 30.8% market share — the highest of any single doxycycline importer. AVET PHARMACEUTICALS INC (UNITED STATES) and J KNIPPER COMPANY (UNITED STATES) are the next largest buyers.
QHow many companies buy doxycycline from India?
There are 1051 active doxycycline buyers importing from India, with a combined market of $118.6M across 5,999 shipments to 149 countries. The top 5 buyers hold 57.2% of total import value, while the remaining 1046 buyers handle the other 42.8%.
QWhich countries import the most doxycycline from India?
The top importing countries for doxycycline from India are United States (78.6%), Australia (4.0%), Ethiopia (2.0%), United Kingdom (1.9%), Belgium (1.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of doxycycline, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for doxycycline from India?
The average import transaction value for doxycycline from India is $19.8K, with an average unit price of $53.40 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Doxycycline buyer market intelligence
1Buyer Segment Analysis
The top 10 buyers of Doxycycline from India predominantly fall into the following categories:
1. Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES, AVET PHARMACEUTICALS INC, and J. KNIPPER & COMPANY are major distributors in the United States. They procure large volumes to supply pharmacies, hospitals, and healthcare providers. Their purchasing behavior is characterized by bulk orders and long-term contracts to ensure consistent supply chains.
2. Contract Manufacturers: Companies such as AMNEAL PHARMACEUTICALS, LLC and MYLAN INSTITUTIONAL INC engage in contract manufacturing. They source active pharmaceutical ingredients (APIs) like Doxycycline for formulation and packaging under various brand names. Their procurement patterns involve substantial quantities aligned with production schedules and market demand forecasts.
3. Third-Party Logistics Providers: CARDINAL THIRD PARTY LOGISTICS represents logistics firms specializing in the storage and distribution of pharmaceutical products. They purchase Doxycycline to manage inventory for multiple clients, ensuring timely delivery to end-users. Their buying behavior is influenced by client needs and market dynamics, leading to variable order sizes and frequencies.
Each segment's purchasing patterns reflect their roles within the pharmaceutical supply chain, with distributors focusing on volume and consistency, contract manufacturers on production requirements, and logistics providers on flexible inventory management.
Country-Specific Import Regulations
TransData Nexus Doxycycline buyer market intelligence
1Country-Specific Import Regulations
United States
1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must file an entry notice and bond with U.S. Customs and Border Protection. The FDA reviews the entry for compliance, which may include sampling and laboratory analysis. Affirmation of Compliance codes, such as Drug Registration Number (REG) and Drug Listing Number (DLS), are recommended to expedite the process.
3. Estimated Timeline for Registration: The review process varies; however, providing complete and accurate documentation can expedite clearance.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this code are generally duty-free, but importers should verify current rates with U.S. Customs.
Australia
1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).
2. Import Registration Process: Medicines must be listed or registered in the Australian Register of Therapeutic Goods (ARTG). Importers must ensure compliance with TGA standards, including Good Manufacturing Practice (GMP) certification.
3. Estimated Timeline for Registration: The registration process can take several months, depending on the complexity of the application and the product's risk classification.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are typically duty-free, but importers should confirm with the Australian Border Force.
Ethiopia
1. Drug Regulatory Authority: Ethiopian Food and Drug Authority (EFDA).
2. Import Registration Process: Importers must obtain pre-import approval from the EFDA, ensuring products meet national standards and are registered accordingly.
3. Estimated Timeline for Registration: The process can take several months, contingent on the completeness of the application and regulatory reviews.
4. Import Tariff/Duty for HS 30049099: Import duties vary; importers should consult the Ethiopian Revenue and Customs Authority for current rates.
United Kingdom
1. Drug Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
2. Import Registration Process: Medicines must be authorized by the MHRA. Importers need a Wholesale Dealer's License, and products must comply with UK standards. The UK recognizes certain countries for importation under specific conditions. (gov.uk)
3. Estimated Timeline for Registration: Timelines vary; straightforward applications may take several months.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally exempt from import duties, but confirmation with HM Revenue & Customs is advisable.
Belgium
1. Drug Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
2. Import Registration Process: Medicines must be authorized by the FAMHP. Importers require a Wholesale Distribution Authorization, and products must comply with EU regulations.
3. Estimated Timeline for Registration: The process can take several months, depending on the product and completeness of the application.
4. Import Tariff/Duty for HS 30049099: As part of the EU, Belgium typically applies a zero-duty rate on pharmaceutical products, but importers should verify with Belgian Customs.
Demand Drivers & Market Opportunity
TransData Nexus Doxycycline buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Doxycycline in importing countries is driven by several factors:
1. Disease Prevalence: Doxycycline is widely used to treat bacterial infections such as respiratory tract infections, acne, and sexually transmitted infections. Its efficacy against a broad spectrum of bacteria makes it a staple in treatment protocols.
2. Government Healthcare Programs: Many countries have national health programs that include Doxycycline in their formularies, ensuring its availability to the population. For instance, the inclusion of Doxycycline in the WHO Model List of Essential Medicines underscores its importance in public health. (who.int)
3. Universal Health Coverage Expansion: As nations strive to achieve universal health coverage, the demand for essential medicines like Doxycycline increases to meet the healthcare needs of the population.
4. WHO Essential Medicines List Procurement: The inclusion of Doxycycline in the WHO Essential Medicines List facilitates its procurement by international health organizations and governments, ensuring its availability in resource-limited settings.
5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender systems, which can lead to bulk purchasing of Doxycycline, influencing market dynamics and pricing.
With 1,051 buyers across 149 countries, the global reach of Doxycycline underscores its critical role in healthcare systems worldwide. The combination of disease prevalence, supportive healthcare policies, and strategic procurement practices continues to drive its demand and presents ongoing market opportunities.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 1051 global importers of Doxycycline identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 5,999 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 149 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,999 Verified Shipments
1051 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists